ANGO
AngioDynamics Inc
15.50$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 35.5% | 37.1% | 60.6% | 60.8% | 58.8% | 60.1% | 60.4% | 60.1% | 59.0% | 59.8% | 59.7% | 61.2% | |
| 11.7% | 12.2% | 24.2% | 23.9% | 18.7% | 18.6% | 15.7% | 20.0% | 14.6% | 15.4% | 14.5% | 20.2% | |
| 11.7% | 12.2% | 24.2% | 23.9% | 18.7% | 18.6% | 15.7% | 20.0% | 14.6% | 15.4% | 14.5% | 20.2% | |
| 10.1% | 10.3% | 15.2% | 15.7% | 13.5% | 14.8% | 17.2% | 15.4% | 16.1% | 16.5% | 17.5% | 18.1% | |
| 12.1% | 12.9% | 17.9% | 19.1% | 22.0% | 22.6% | 22.1% | 22.1% | 23.4% | 24.3% | 22.5% | 19.6% | |
| 9.7% | – | – | – | – | – | – | – | – | – | – | – | |
| 32.2% | 31.9% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 21.6% | 20.8% | 25.1% | 24.4% | 25.8% | 25.1% | 24.9% | 24.7% | 25.7% | 24.7% | 25.1% | 25.2% | |
| 13.4% | 19.7% | 32.7% | 35.3% | 33.1% | 35.9% | 34.9% | 34.7% | 32.7% | 34.6% | 33.5% | 36.1% | |
| 11.6% | 15.6% | 26.4% | 28.7% | 26.1% | 30.4% | 27.3% | 27.2% | 25.7% | 26.7% | 25.3% | 28.0% | |
| 1.0% | 0.3% | 0.5% | 1.5% | 1.6% | 1.7% | 1.8% | 0.8% | 0.8% | 0.6% | 0.7% | – | |
| 5.0% | 7.5% | 10.8% | 11.9% | 10.7% | 11.9% | 10.6% | 11.9% | 12.0% | 13.1% | 11.2% | 11.8% | |
| 86.6% | 80.3% | 67.3% | 64.7% | 66.9% | 64.1% | 65.1% | 65.3% | 67.3% | 65.4% | 66.5% | 63.9% | |
| -33.4% | -38.8% | -117.5% | -124.4% | -139.0% | -143.6% | -148.3% | -153.2% | -165.7% | -165.5% | -174.4% | -174.4% | |
| 8.1% | 8.0% | 12.4% | 12.7% | 13.8% | 14.0% | 14.3% | 14.6% | 15.5% | 15.4% | 16.0% | 15.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.